gonorrhoea
Rollout of world-first gonorrhoea vaccine programme begins under NHS
August 8, 2025Medical Communications 10 Year Health Plan, Genito-Urinary system, Infections and infestations, NHS, gonorrhoea, sexual health, sexually transmitted infections, vaccination
From 4 August, sexual health clinics in England have been able to offer a free vaccine – the 4CMenB vaccine …
GSK shares results from phase 3 trial for gonorrhoea treatment
April 18, 2024Research and Development GSK, Reproductive health, clinical trial, gonorrhoea, sexual health
GSK has announced positive results from its phase 3 EAGLE-1 trial for gepotidacin, a potential first-in-class oral antibiotic for the …
GSK shares positive results from phase 3 trial for gonorrhoea treatment
February 27, 2024Research and Development GSK, Infections and infestations, antibiotic, clinical trial, gonorrhoea
GSK has announced positive headline results from its phase 3 EAGLE-1 trial for gepotidacin, its potential first-in-class oral antibiotic with …
GSK receives FDA Fast Track designation for novel gonorrhoea vaccine
June 27, 2023Research and Development FDA, GSK, Infections and infestations, Vaccine, fast track designation, gonorrhoea
GSK has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for its investigational vaccine …
FDA approves new tests for chlamydia and gonorrhoea
May 24, 2019Medical Communications STIs, chlamydia, gonorrhoea, public health FDA
The FDA has approved two new tests which make it easier to diagnose common STIs. The approval comes after a …
Investigational antibiotic shows high cure rates in gonorrhoea at Phase 2
November 8, 2018Research and Development National Institute of Allergy and Infectious Diseases, National Institutes of Health, gonorrhoea, pharma, zoliflodacin
A Phase 2 study sponsored by The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National …
Gonorrhoea is just the tip of the antimicrobial resistance iceberg
October 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical
Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …
Hope in quest for gonorrhoea vaccination
July 11, 2017Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination
Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …
Oral sex creating super-gonorrhoea
July 7, 2017Research and Development antibiotic resistance, gonorrhoea
The WHO has announced that data from across 77 different countries show that the sexually-transmitted infection (STI) gonorrhoea is becoming …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
